2012;302:E33443
Similarly, our data indicate differential efficacy by ancestry (Supplementary Table 4), with GLP1 medications being most effective in people of European ancestry, less effective in people of Latino ancestry and least effective in people of African American ancestry
J Nutr 150: 20612069, 2020
Working with a practitioner experienced in mold toxicity supports: Accurate identification of environmental exposure drivers Appropriate selection and interpretation of functional testing Proper sequencing that prioritizes stabilization before detoxification Reduction of inflammatory burden without triggering unnecessary flares Structured progression toward long-term recovery When mold-related illness is evaluated within a systems-based framework, care can focus on resolving root contributors rather than cycling through temporary interventions
doi: 10.1007/s10517-007-0441-z
Mok J, Adeleke MO, Brown A, Magee CG, Firman C, Makahamadze C, et al